With such a valuable mission, I’m looking forward to being part of its continued growth as the company goes from strength to strength”.Īdam Hildreth, CEO and Founder of Crisp, said: We’ve seen over recent years, and particularly this year, how tech has the ability to transform lives and bring us together, but also how it can be used to do harm to innocent organizations and individuals.Ĭrisp’s work harnessing the power of data to help brands and social media platforms keep the internet safe for everyone is inspiring. “I’m really excited to become Crisp’s Chief Data Officer and to join an experienced executive team focussed on delivering a strong purpose. Kevin Fletcher, Crisp’s newly-appointed Chief Data Officer, said: As a result, Crisp contributes to the safe, daily online experiences of more than two billion users, covering an estimated 450 million children. Its Real-time Risk Intelligence Graph, trained on 15+ years of online harm detection, uncovers the invisible connections between actors and other fringe groups and, between their behaviours, discussions and other social signals - all to discover, track, rapidly alert and remove inauthentic and harmful content. The firm protects more than $6.5 trillion of combined market capitalisation for its customers.Ĭrisp’s core belief is that inauthentic, illegal, harmful and hateful content originates and spreads from specific groups of bad actors, so it focuses on following these actors across the closed, open and dark social channels they use, analysing billions of pieces of their online social conversations. Predominantly selling to the US market, the company hit an annualised recurring revenue of over $36m in 2020, an increase of 60% from 2019.įounded in 2005 by Adam Hildreth, Crisp analyses online social chatter to provide 24/7/365 early-warning risk intelligence for leading brands, global enterprises, and social media platforms. Crisp’s growth in recent years has seen its headcount grow from 68 in 2017 to over 200 today, and it’s looking to fill an additional 30 open roles across the business in the early part of 2021. His remit at Crisp will be to lead the company’s growing data team and define the direction, structure, processes and standards for Data Science across the company.

Sitting on a number of industry advisory and steering boards, Fletcher has also been recognised at number seven on the DataIQ 100 list of data leaders. Previously the Chief Data Officer at HMRC, the appointment of Fletcher follows a year of strong growth and continued expansion for Crisp in international markets.Īt HMRC, Fletcher setup and established the Chief Data Office, created the organisation’s first ever data strategy, developed its data governance and management capability, and built a Data Science team that unlocked revenue gains and efficiency savings. He has authored several publications in leading scientific and business journals.Leeds-based Crisp, the leading provider of early-warning risk intelligence, has announced the appointment of Kevin Fletcher as its new Chief Data Officer.

While at the University of Washington, he conducted research on the delivery of biological drugs and in the field of molecular diagnostics. in Bioengineering and Nanotechnology from the University of Washington and a B. He also serves on the Board of the Emerging Companies Section of the Biotechnology Innovation Organization (BIO).

Sam currently serves on the Board of Directors of two precision oncology companies, Black Diamond Therapeutics and Repare Therapeutics. Previously, Sam served as the Chairman of the Board of Directors of Casebia Therapeutics, a joint subsidiary formed by CRISPR Therapeutics and Bayer. While at McKinsey, he co-led the biotech practice, where he focused on strategy and operations, and led initiatives in areas such as personalized medicine and immunotherapy. Prior to joining our company, Sam was a Partner at McKinsey & Company, where he had a leading role in the Pharmaceutical and Medical products practice. He joined CRISPR in 2015 in the early stages of the company as Chief Business Officer, and then was appointed to President and Chief Business Officer before becoming CEO. He has significant expertise in strategy and operations in biotech and a wide range of related cutting-edge therapeutic technologies. Samarth Kulkarni has served as our Chief Executive Officer since 2017.

Ceo of ecrisper